310 related articles for article (PubMed ID: 33080774)
1. Tumor Treating Fields (TTFields) Hinder Cancer Cell Motility through Regulation of Microtubule and Acting Dynamics.
Voloshin T; Schneiderman RS; Volodin A; Shamir RR; Kaynan N; Zeevi E; Koren L; Klein-Goldberg A; Paz R; Giladi M; Bomzon Z; Weinberg U; Palti Y
Cancers (Basel); 2020 Oct; 12(10):. PubMed ID: 33080774
[TBL] [Abstract][Full Text] [Related]
2. Tumor treating fields: a new frontier in cancer therapy.
Davies AM; Weinberg U; Palti Y
Ann N Y Acad Sci; 2013 Jul; 1291():86-95. PubMed ID: 23659608
[TBL] [Abstract][Full Text] [Related]
3. Mitotic Spindle Disruption by Alternating Electric Fields Leads to Improper Chromosome Segregation and Mitotic Catastrophe in Cancer Cells.
Giladi M; Schneiderman RS; Voloshin T; Porat Y; Munster M; Blat R; Sherbo S; Bomzon Z; Urman N; Itzhaki A; Cahal S; Shteingauz A; Chaudhry A; Kirson ED; Weinberg U; Palti Y
Sci Rep; 2015 Dec; 5():18046. PubMed ID: 26658786
[TBL] [Abstract][Full Text] [Related]
4. A Review on Tumor-Treating Fields (TTFields): Clinical Implications Inferred From Computational Modeling.
Wenger C; Miranda PC; Salvador R; Thielscher A; Bomzon Z; Giladi M; Mrugala MM; Korshoej AR
IEEE Rev Biomed Eng; 2018; 11():195-207. PubMed ID: 29993870
[TBL] [Abstract][Full Text] [Related]
5. Tumor Treating Fields: At the Crossroads Between Physics and Biology for Cancer Treatment.
Carrieri FA; Smack C; Siddiqui I; Kleinberg LR; Tran PT
Front Oncol; 2020; 10():575992. PubMed ID: 33215030
[TBL] [Abstract][Full Text] [Related]
6. Real-Time Monitoring of the Effect of Tumour-Treating Fields on Cell Division Using Live-Cell Imaging.
Le HT; Staelens M; Lazzari D; Chan G; Tuszyński JA
Cells; 2022 Aug; 11(17):. PubMed ID: 36078119
[TBL] [Abstract][Full Text] [Related]
7. Integration of Tumor-Treating Fields into the Multidisciplinary Management of Patients with Solid Malignancies.
Wang Y; Pandey M; Ballo MT
Oncologist; 2019 Dec; 24(12):e1426-e1436. PubMed ID: 31444292
[TBL] [Abstract][Full Text] [Related]
8. Treatment with tumor-treating fields (TTFields) suppresses intercellular tunneling nanotube formation in vitro and upregulates immuno-oncologic biomarkers in vivo in malignant mesothelioma.
Sarkari A; Korenfeld S; Deniz K; Ladner K; Wong P; Padmanabhan S; Vogel RI; Sherer LA; Courtemanche N; Steer C; Wainer-Katsir K; Lou E
Elife; 2023 Nov; 12():. PubMed ID: 37955637
[TBL] [Abstract][Full Text] [Related]
9. Prevention and Management of Dermatologic Adverse Events Associated With Tumor Treating Fields in Patients With Glioblastoma.
Lacouture ME; Anadkat MJ; Ballo MT; Iwamoto F; Jeyapalan SA; La Rocca RV; Schwartz M; Serventi JN; Glas M
Front Oncol; 2020; 10():1045. PubMed ID: 32850308
[No Abstract] [Full Text] [Related]
10. Tumor treating fields (TTFields) delay DNA damage repair following radiation treatment of glioma cells.
Giladi M; Munster M; Schneiderman RS; Voloshin T; Porat Y; Blat R; Zielinska-Chomej K; Hååg P; Bomzon Z; Kirson ED; Weinberg U; Viktorsson K; Lewensohn R; Palti Y
Radiat Oncol; 2017 Dec; 12(1):206. PubMed ID: 29284495
[TBL] [Abstract][Full Text] [Related]
11. Modeling Tumor Treating fields (TTFields) application within a realistic human head model.
Wenger C; Salvador R; Basser PJ; Miranda PC
Annu Int Conf IEEE Eng Med Biol Soc; 2015; 2015():2555-8. PubMed ID: 26736813
[TBL] [Abstract][Full Text] [Related]
12. The dielectric properties of skin and their influence on the delivery of tumor treating fields to the torso: a study combining in vivo measurements with numerical simulations.
Hershkovich HS; Urman N; Yesharim O; Naveh A; Bomzon Z
Phys Med Biol; 2019 Sep; 64(18):185014. PubMed ID: 31323651
[TBL] [Abstract][Full Text] [Related]
13. Can tumor treating fields induce DNA damage and reduce cell motility in medulloblastoma cell lines?
Nitta RT; Luo EJ; Lim M; Li G
J Neurosurg Pediatr; 2022 Dec; 30(6):555-566. PubMed ID: 36208441
[TBL] [Abstract][Full Text] [Related]
14. Expert guidance on prophylaxis and treatment of dermatologic adverse events with Tumor Treating Fields (TTFields) therapy in the thoracic region.
Anadkat MJ; Lacouture M; Friedman A; Horne ZD; Jung J; Kaffenberger B; Kalmadi S; Ovington L; Kotecha R; Abdullah HI; Grosso F
Front Oncol; 2022; 12():975473. PubMed ID: 36703794
[TBL] [Abstract][Full Text] [Related]
15. A review of tumor treating fields (TTFields): advancements in clinical applications and mechanistic insights.
Li X; Liu K; Xing L; Rubinsky B
Radiol Oncol; 2023 Sep; 57(3):279-291. PubMed ID: 37665740
[TBL] [Abstract][Full Text] [Related]
16. The schemes, mechanisms and molecular pathway changes of Tumor Treating Fields (TTFields) alone or in combination with radiotherapy and chemotherapy.
Tanzhu G; Chen L; Xiao G; Shi W; Peng H; Chen D; Zhou R
Cell Death Discov; 2022 Oct; 8(1):416. PubMed ID: 36220835
[TBL] [Abstract][Full Text] [Related]
17. Alternating electric fields (tumor-treating fields therapy) can improve chemotherapy treatment efficacy in non-small cell lung cancer both in vitro and in vivo.
Giladi M; Weinberg U; Schneiderman RS; Porat Y; Munster M; Voloshin T; Blatt R; Cahal S; Itzhaki A; Onn A; Kirson ED; Palti Y
Semin Oncol; 2014 Oct; 41 Suppl 6():S35-41. PubMed ID: 25213867
[TBL] [Abstract][Full Text] [Related]
18. Electrodynamic interaction between tumor treating fields and microtubule electrophysiological activities.
Li X; Liu K; Fang H; Liu Z; Tang Y; Dai P
APL Bioeng; 2024 Jun; 8(2):026118. PubMed ID: 38841689
[TBL] [Abstract][Full Text] [Related]
19. An Overview of Sub-Cellular Mechanisms Involved in the Action of TTFields.
Tuszynski JA; Wenger C; Friesen DE; Preto J
Int J Environ Res Public Health; 2016 Nov; 13(11):. PubMed ID: 27845746
[TBL] [Abstract][Full Text] [Related]
20. Current status of the preclinical evaluation of alternating electric fields as a form of cancer therapy.
Pohling C; Nguyen H; Chang E; Schubert KE; Nie Y; Bashkirov V; Yamamoto V; Zeng Y; Stupp R; Schulte RW; Patel CB
Bioelectrochemistry; 2023 Feb; 149():108287. PubMed ID: 36306728
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
